Suppr超能文献

在印度尼西亚日惹市,让私人医生介绍疑似肺结核患者到直接督导下的短程化疗服务(DOTS)中,增加的成本效益。

The incremental cost-effectiveness of engaging private practitioners to refer tuberculosis suspects to DOTS services in Jogjakarta, Indonesia.

机构信息

Department of Public Health, Faculty of Medicine, Gadjah Mada University, Jogjakarta, Indonesia.

出版信息

Am J Trop Med Hyg. 2010 Jun;82(6):1131-9. doi: 10.4269/ajtmh.2010.09-0447.

Abstract

We aimed to evaluate the incremental cost-effectiveness of engaging private practitioners (PPs) to refer tuberculosis (TB) suspects to public health centers in Jogjakarta, Indonesia. Effectiveness was assessed for TB suspects notified between May 2004 and April 2005. Private practitioners referred 1,064 TB suspects, of which 57.5% failed to reach a health center. The smear-positive rate among patients reaching a health center was 61.8%. Two hundred eighty (280) out of a total of 1,306 (21.4%) new smear-positive cases were enrolled through the PPs strategy. The incremental cost-effectiveness ratio per smear-positive case successfully treated for the PPs strategy was US$351.66 (95% CI 322.84-601.33). On the basis of an acceptability curve using the National TB control program's willingness-to-pay threshold (US$448.61), we estimate the probability that the PPs strategy is cost-effective at 66.8%. The strategy of engaging PPs was incrementally cost-effective, although under specific conditions, most importantly a well-functioning public directly observed treatment, short-course (DOTS) program.

摘要

我们旨在评估在印度尼西亚日惹市聘请私人医生(PPs)将结核病(TB)疑似病例转介到公共卫生中心的增量成本效益。评估了 2004 年 5 月至 2005 年 4 月间通报的 TB 疑似病例的有效性。私人医生转诊了 1064 例 TB 疑似病例,其中 57.5%未到达卫生中心。到达卫生中心的患者中涂片阳性率为 61.8%。通过私人医生策略共登记了总共 1306 例新的涂片阳性病例中的 280 例(21.4%)。私人医生策略每成功治疗一例涂片阳性病例的增量成本效益比为 351.66 美元(95%CI 322.84-601.33)。基于使用国家结核病控制规划支付意愿阈值(448.61 美元)的可接受性曲线,我们估计私人医生策略具有成本效益的概率为 66.8%。尽管在特定条件下,特别是在运行良好的公共直接观察治疗短程化疗(DOTS)方案下,聘请私人医生的策略具有增量成本效益。

相似文献

4
[Tuberculosis in Asia].
Kekkaku. 2002 Oct;77(10):693-7.
5
Private practitioners and tuberculosis case detection in Jogjakarta, Indonesia: actual role and potential.
Trop Med Int Health. 2007 Oct;12(10):1218-24. doi: 10.1111/j.1365-3156.2007.01946.x.
8
Control of tuberculosis in an urban setting in Nepal: public-private partnership.
Bull World Health Organ. 2004 Feb;82(2):92-8. Epub 2004 Mar 16.
9
Engaging general practitioners in public-private mix tuberculosis DOTS program in an urban area in Pakistan: need for context-specific approach.
Asia Pac J Public Health. 2015 Mar;27(2):NP984-92. doi: 10.1177/1010539513483828. Epub 2013 Apr 9.

引用本文的文献

1
Successful treatment of tuberculosis using a collaborative approach between family and health workers.
J Public Health Afr. 2023 Nov 30;14(11):2455. doi: 10.4081/jphia.2023.2455.
2
Health economic evaluations for Indonesia: a systematic review assessing evidence quality and adherence to the Indonesian Health Technology Assessment (HTA) Guideline.
Lancet Reg Health Southeast Asia. 2023 Mar 31;13:100184. doi: 10.1016/j.lansea.2023.100184. eCollection 2023 Jun.
3
Cost and affordability of scaling up tuberculosis diagnosis using Xpert MTB/RIF testing in West Java, Indonesia.
PLoS One. 2022 Mar 10;17(3):e0264912. doi: 10.1371/journal.pone.0264912. eCollection 2022.
10
Patients' willingness to pay for the treatment of tuberculosis in Nigeria: exploring own use and altruism.
Int J Equity Health. 2017 May 10;16(1):74. doi: 10.1186/s12939-017-0574-2.

本文引用的文献

2
Private practitioners and tuberculosis case detection in Jogjakarta, Indonesia: actual role and potential.
Trop Med Int Health. 2007 Oct;12(10):1218-24. doi: 10.1111/j.1365-3156.2007.01946.x.
4
Costs of a successful public-private partnership for TB control in an urban setting in Nepal.
BMC Public Health. 2007 May 18;7:84. doi: 10.1186/1471-2458-7-84.
5
MDR and XDR - the price of delaying engagement with all care providers for control of TB and TB/HIV.
Trop Med Int Health. 2007 Apr;12(4):473-4. doi: 10.1111/j.1365-3156.2007.01839.x.
7
Engaging the private sector for tuberculosis control: much advocacy on a meagre evidence base.
Trop Med Int Health. 2007 Mar;12(3):315-6. doi: 10.1111/j.1365-3156.2007.01816.x.
9
Cost and cost-effectiveness of PPM-DOTS for tuberculosis control: evidence from India.
Bull World Health Organ. 2006 Jun;84(6):437-45. doi: 10.2471/blt.05.024109. Epub 2006 Jun 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验